Free tool
Stocks listed on Nasdaq GS
We cover 33 companies listed on Nasdaq GS. The median market value in the group is $1.87B. Across the group, the median move over the past trading day is −0.07%. 100% of the 32 with a 200-day average trade above it. Price change over the past year runs from +0.4% to +290.3% across the middle 80 percent of the group, with a median of +73.5%.
Other lists in this group
Table
33 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% |
| CCRN | Cross Country Healthcare Inc | $428.06M | Small cap | +0.38% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.